Biliary elimination of bromsulphthalein, phenolphthalein, and doxorubicin released from microspheres following intravenous administration
- 1 March 1993
- journal article
- research article
- Published by Wiley in Biopharmaceutics & Drug Disposition
- Vol. 14 (2) , 181-186
- https://doi.org/10.1002/bdd.2510140209
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Injection site dependence of the appearance of sulfobromophthalein and phenolphthalein in bileBiopharmaceutics & Drug Disposition, 1991
- Factorial design based optimization of the formulation of albumin microspheres containing adriamycinJournal of Microencapsulation, 1989
- Porous Biodegradable Microspheres for Controlled Drug Delivery. I. Assessment of Processing Conditions and Solvent Removal TechniquesPharmaceutical Research, 1988
- Increased tight junction permeability: a possible mechanism of oestrogen cholestasisEuropean Journal of Clinical Investigation, 1983
- A New Long-Acting Injectable Microcapsule System for the Administration of ProgesteroneFertility and Sterility, 1979
- AdriamycinAnnals of Internal Medicine, 1974
- BILIRUBIN, BROMSULPHTHALEIN AND INDOCYANINE GREEN EXCRETION IN BILQuarterly Journal of Experimental Physiology and Cognate Medical Sciences, 1966
- The application of thin layer chromatography to sulfobromophthalein metabolism studiesToxicology and Applied Pharmacology, 1963
- Metabolism of SulphobromophthaleinNature, 1959
- Tissue fractionation studies. 4. Comparative study of the binding of acid phosphatase, β-glucuronidase and cathepsin by rat-liver particlesBiochemical Journal, 1955